Molecular Research of Neurological and Psychiatric Disorders

Dear Colleagues,

Neurological and psychiatric disorders affect millions globally, impacting the quality of life and productivity, and imposing significant burdens on healthcare systems. The etiology of neurological and psychiatric disorders is notoriously complex, involving intricate interplays of genetic, environmental and neurobiological factors. Molecular research holds the key to decoding these interactions, identifying disease mechanisms and uncovering potential points of intervention.

The Special Issue aims to explore the intricate molecular mechanisms underlying neurological and psychiatric conditions, fostering a deeper understanding of their etiology, progression and potential therapeutic targets. This issue will focus on the latest molecular biology techniques, genetic findings and biochemical pathways involved in disorders such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, schizophrenia, depression, and bipolar disorder and autism spectrum disorders. An emphasis will be placed on cutting-edge research that unveils the role of genetic variations, epigenetic modifications, neurotransmitter dysregulation and protein misfolding in the pathogenesis of these complex diseases. By highlighting innovative studies on molecular diagnostics, biomarker discovery and the development of novel therapeutic strategies, this Special Issue seeks to bridge the gap between molecular insights and clinical applications, offering hope for patients and advancements in personalized medicine. Through interdisciplinary research and collaboration, it aims to contribute significantly to the understanding of the molecular basis of neurological and psychiatric disorders, paving the way for more effective treatments and interventions.

Dr. Yuen Gao
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• molecular biology
• neurodegenerative disorders
• psychiatry
• biomarkers
• therapeutic targets